Australian scientists create nanotech chemo delivery vehicle

05/10/2007 | Reuters

Australia-based EnGeneIC says it has developed nano-cells derived from bacteria that target cancer cells and deliver chemotherapy in significantly lower doses. The EnGeneIC delivery vehicles has had positive results in primate trials and the goal is to help patients more easily tolerate chemo treatment. A researcher said, "For the first time there is a real possibility that this technology could lead to the use of multi-drug combinations and eventual custom-made therapies in cancer patients."

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Fort Worth, TX